dipotassium;1-[4-(azetidin-3-yl)piperazin-1-yl]-2,2,2-trifluoroethanone;hydride;methanol;oxido formate;(3-piperazin-1-ylazetidin-1-yl)-(1,2,3,4-tetrahydroquinolin-6-yl)methanone;1,2,3,4-tetrahydroquinoline-6-carboxylic acid;1,2,3,4-tetrahydroquinolin-6-yl-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;1,3-thiazole-2-carboxylic acid;2,2,2-trifluoro-1-[4-[1-(1,2,3,4-tetrahydroquinoline-6-carbonyl)azetidin-3-yl]piperazin-1-yl]ethanone

C82H106F6K2N18O14S2 — CID 162166477

IUPACdipotassium;1-[4-(azetidin-3-yl)piperazin-1-yl]-2,2,2-trifluoroethanone;hydride;methanol;oxido formate;(3-piperazin-1-ylazetidin-1-yl)-(1,2,3,4-tetrahydroquinolin-6-yl)methanone;1,2,3,4-tetrahydroquinoline-6-carboxylic acid;1,2,3,4-tetrahydroquinolin-6-yl-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;1,3-thiazole-2-carboxylic acid;2,2,2-trifluoro-1-[4-[1-(1,2,3,4-tetrahydroquinoline-6-carbonyl)azetidin-3-yl]piperazin-1-yl]ethanone
SMILESCO.O=C(N1CCN(C2CNC2)CC1)C(F)(F)F.O=C(O)c1ccc2c(c1)CCCN2.O=C(O)c1nccs1.O=C(c1ccc2c(c1)CCCN2)N1CC(N2CCN(C(=O)C(F)(F)F)CC2)C1.O=C(c1ccc2c(c1)CCCN2)N1CC(N2CCN(C(=O)c3nccs3)CC2)C1.O=C(c1ccc2c(c1)CCCN2)N1CC(N2CCNCC2)C1.O=CO[O-].[H-].[K+].[K+]
InChIInChI=1S/C21H25N5O2S.C19H23F3N4O2.C17H24N4O.C10H11NO2.C9H14F3N3O.C4H3NO2S.CH2O3.CH4O.2K.H/c27-20(16-3-4-18-15(12-16)2-1-5-22-18)26-13-17(14-26)24-7-9-25(10-8-24)21(28)19-23-6-11-29-19;20-19(21,22)18(28)25-8-6-24(7-9-25)15-11-26(12-15)17(27)14-3-4-16-13(10-14)2-1-5-23-16;22-17(14-3-4-16-13(10-14)2-1-5-19-16)21-11-15(12-21)20-8-6-18-7-9-20;12-10(13)8-3-4-9-7(6-8)2-1-5-11-9;10-9(11,12)8(16)15-3-1-14(2-4-15)7-5-13-6-7;6-4(7)3-5-1-2-8-3;2-1-4-3;1-2;;;/h3-4,6,11-12,17,22H,1-2,5,7-10,13-14H2;3-4,10,15,23H,1-2,5-9,11-12H2;3-4,10,15,18-19H,1-2,5-9,11-12H2;3-4,6,11H,1-2,5H2,(H,12,13);7,13H,1-6H2;1-2H,(H,6,7);1,3H;2H,1H3;;;/q;;;;;;;;2*+1;-1/p-1
InChIKeyNJQHYHKRRYOODI-UHFFFAOYSA-M
MW1824.18 g/mol
LogP-1.45
Rot. Bonds11

About dipotassium;1-[4-(azetidin-3-yl)piperazin-1-yl]-2,2,2-trifluoroethanone;hydride;methanol;oxido formate;(3-piperazin-1-ylazetidin-1-yl)-(1,2,3,4-tetrahydroquinolin-6-yl)methanone;1,2,3,4-tetrahydroquinoline-6-carboxylic acid;1,2,3,4-tetrahydroquinolin-6-yl-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;1,3-thiazole-2-carboxylic acid;2,2,2-trifluoro-1-[4-[1-(1,2,3,4-tetrahydroquinoline-6-carbonyl)azetidin-3-yl]piperazin-1-yl]ethanone

dipotassium;1-[4-(azetidin-3-yl)piperazin-1-yl]-2,2,2-trifluoroethanone;hydride;methanol;oxido formate;(3-piperazin-1-ylazetidin-1-yl)-(1,2,3,4-tetrahydroquinolin-6-yl)methanone;1,2,3,4-tetrahydroquinoline-6-carboxylic acid;1,2,3,4-tetrahydroquinolin-6-yl-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;1,3-thiazole-2-carboxylic acid;2,2,2-trifluoro-1-[4-[1-(1,2,3,4-tetrahydroquinoline-6-carbonyl)azetidin-3-yl]piperazin-1-yl]ethanone (PubChem CID 162166477) has the molecular formula C82H106F6K2N18O14S2 and a molecular weight of 1824.18 g/mol. Its IUPAC name is dipotassium;1-[4-(azetidin-3-yl)piperazin-1-yl]-2,2,2-trifluoroethanone;hydride;methanol;oxido formate;(3-piperazin-1-ylazetidin-1-yl)-(1,2,3,4-tetrahydroquinolin-6-yl)methanone;1,2,3,4-tetrahydroquinoline-6-carboxylic acid;1,2,3,4-tetrahydroquinolin-6-yl-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;1,3-thiazole-2-carboxylic acid;2,2,2-trifluoro-1-[4-[1-(1,2,3,4-tetrahydroquinoline-6-carbonyl)azetidin-3-yl]piperazin-1-yl]ethanone.

Molecular Properties

Compound Namedipotassium;1-[4-(azetidin-3-yl)piperazin-1-yl]-2,2,2-trifluoroethanone;hydride;methanol;oxido formate;(3-piperazin-1-ylazetidin-1-yl)-(1,2,3,4-tetrahydroquinolin-6-yl)methanone;1,2,3,4-tetrahydroquinoline-6-carboxylic acid;1,2,3,4-tetrahydroquinolin-6-yl-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;1,3-thiazole-2-carboxylic acid;2,2,2-trifluoro-1-[4-[1-(1,2,3,4-tetrahydroquinoline-6-carbonyl)azetidin-3-yl]piperazin-1-yl]ethanone
PubChem CID162166477
Molecular FormulaC82H106F6K2N18O14S2
Molecular Weight1824.18 g/mol
Exact Mass1822.68
IUPAC Namedipotassium;1-[4-(azetidin-3-yl)piperazin-1-yl]-2,2,2-trifluoroethanone;hydride;methanol;oxido formate;(3-piperazin-1-ylazetidin-1-yl)-(1,2,3,4-tetrahydroquinolin-6-yl)methanone;1,2,3,4-tetrahydroquinoline-6-carboxylic acid;1,2,3,4-tetrahydroquinolin-6-yl-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;1,3-thiazole-2-carboxylic acid;2,2,2-trifluoro-1-[4-[1-(1,2,3,4-tetrahydroquinoline-6-carbonyl)azetidin-3-yl]piperazin-1-yl]ethanone
SMILESCO.O=C(N1CCN(C2CNC2)CC1)C(F)(F)F.O=C(O)c1ccc2c(c1)CCCN2.O=C(O)c1nccs1.O=C(c1ccc2c(c1)CCCN2)N1CC(N2CCN(C(=O)C(F)(F)F)CC2)C1.O=C(c1ccc2c(c1)CCCN2)N1CC(N2CCN(C(=O)c3nccs3)CC2)C1.O=C(c1ccc2c(c1)CCCN2)N1CC(N2CCNCC2)C1.O=CO[O-].[H-].[K+].[K+]
InChIInChI=1S/C21H25N5O2S.C19H23F3N4O2.C17H24N4O.C10H11NO2.C9H14F3N3O.C4H3NO2S.CH2O3.CH4O.2K.H/c27-20(16-3-4-18-15(12-16)2-1-5-22-18)26-13-17(14-26)24-7-9-25(10-8-24)21(28)19-23-6-11-29-19;20-19(21,22)18(28)25-8-6-24(7-9-25)15-11-26(12-15)17(27)14-3-4-16-13(10-14)2-1-5-23-16;22-17(14-3-4-16-13(10-14)2-1-5-19-16)21-11-15(12-21)20-8-6-18-7-9-20;12-10(13)8-3-4-9-7(6-8)2-1-5-11-9;10-9(11,12)8(16)15-3-1-14(2-4-15)7-5-13-6-7;6-4(7)3-5-1-2-8-3;2-1-4-3;1-2;;;/h3-4,6,11-12,17,22H,1-2,5,7-10,13-14H2;3-4,10,15,23H,1-2,5-9,11-12H2;3-4,10,15,18-19H,1-2,5-9,11-12H2;3-4,6,11H,1-2,5H2,(H,12,13);7,13H,1-6H2;1-2H,(H,6,7);1,3H;2H,1H3;;;/q;;;;;;;;2*+1;-1/p-1
InChIKeyNJQHYHKRRYOODI-UHFFFAOYSA-M
XLogP-1.45
TPSA376.97 Ų
H-Bond Donors9
H-Bond Acceptors26
Rotatable Bonds11
Heavy Atoms124
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001824.18
LogP ≤ 5-1.45
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'peroxide', 'substructure': 'N/A'}

Analyze dipotassium;1-[4-(azetidin-3-yl)piperazin-1-yl]-2,2,2-trifluoroethanone;hydride;methanol;oxido formate;(3-piperazin-1-ylazetidin-1-yl)-(1,2,3,4-tetrahydroquinolin-6-yl)methanone;1,2,3,4-tetrahydroquinoline-6-carboxylic acid;1,2,3,4-tetrahydroquinolin-6-yl-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;1,3-thiazole-2-carboxylic acid;2,2,2-trifluoro-1-[4-[1-(1,2,3,4-tetrahydroquinoline-6-carbonyl)azetidin-3-yl]piperazin-1-yl]ethanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of dipotassium;1-[4-(azetidin-3-yl)piperazin-1-yl]-2,2,2-trifluoroethanone;hydride;methanol;oxido formate;(3-piperazin-1-ylazetidin-1-yl)-(1,2,3,4-tetrahydroquinolin-6-yl)methanone;1,2,3,4-tetrahydroquinoline-6-carboxylic acid;1,2,3,4-tetrahydroquinolin-6-yl-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;1,3-thiazole-2-carboxylic acid;2,2,2-trifluoro-1-[4-[1-(1,2,3,4-tetrahydroquinoline-6-carbonyl)azetidin-3-yl]piperazin-1-yl]ethanone?
The IUPAC name of dipotassium;1-[4-(azetidin-3-yl)piperazin-1-yl]-2,2,2-trifluoroethanone;hydride;methanol;oxido formate;(3-piperazin-1-ylazetidin-1-yl)-(1,2,3,4-tetrahydroquinolin-6-yl)methanone;1,2,3,4-tetrahydroquinoline-6-carboxylic acid;1,2,3,4-tetrahydroquinolin-6-yl-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;1,3-thiazole-2-carboxylic acid;2,2,2-trifluoro-1-[4-[1-(1,2,3,4-tetrahydroquinoline-6-carbonyl)azetidin-3-yl]piperazin-1-yl]ethanone (CID 162166477) is dipotassium;1-[4-(azetidin-3-yl)piperazin-1-yl]-2,2,2-trifluoroethanone;hydride;methanol;oxido formate;(3-piperazin-1-ylazetidin-1-yl)-(1,2,3,4-tetrahydroquinolin-6-yl)methanone;1,2,3,4-tetrahydroquinoline-6-carboxylic acid;1,2,3,4-tetrahydroquinolin-6-yl-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;1,3-thiazole-2-carboxylic acid;2,2,2-trifluoro-1-[4-[1-(1,2,3,4-tetrahydroquinoline-6-carbonyl)azetidin-3-yl]piperazin-1-yl]ethanone.
What is the SMILES notation for dipotassium;1-[4-(azetidin-3-yl)piperazin-1-yl]-2,2,2-trifluoroethanone;hydride;methanol;oxido formate;(3-piperazin-1-ylazetidin-1-yl)-(1,2,3,4-tetrahydroquinolin-6-yl)methanone;1,2,3,4-tetrahydroquinoline-6-carboxylic acid;1,2,3,4-tetrahydroquinolin-6-yl-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;1,3-thiazole-2-carboxylic acid;2,2,2-trifluoro-1-[4-[1-(1,2,3,4-tetrahydroquinoline-6-carbonyl)azetidin-3-yl]piperazin-1-yl]ethanone?
The canonical SMILES for dipotassium;1-[4-(azetidin-3-yl)piperazin-1-yl]-2,2,2-trifluoroethanone;hydride;methanol;oxido formate;(3-piperazin-1-ylazetidin-1-yl)-(1,2,3,4-tetrahydroquinolin-6-yl)methanone;1,2,3,4-tetrahydroquinoline-6-carboxylic acid;1,2,3,4-tetrahydroquinolin-6-yl-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;1,3-thiazole-2-carboxylic acid;2,2,2-trifluoro-1-[4-[1-(1,2,3,4-tetrahydroquinoline-6-carbonyl)azetidin-3-yl]piperazin-1-yl]ethanone is CO.O=C(N1CCN(C2CNC2)CC1)C(F)(F)F.O=C(O)c1ccc2c(c1)CCCN2.O=C(O)c1nccs1.O=C(c1ccc2c(c1)CCCN2)N1CC(N2CCN(C(=O)C(F)(F)F)CC2)C1.O=C(c1ccc2c(c1)CCCN2)N1CC(N2CCN(C(=O)c3nccs3)CC2)C1.O=C(c1ccc2c(c1)CCCN2)N1CC(N2CCNCC2)C1.O=CO[O-].[H-].[K+].[K+].
What is the InChIKey of dipotassium;1-[4-(azetidin-3-yl)piperazin-1-yl]-2,2,2-trifluoroethanone;hydride;methanol;oxido formate;(3-piperazin-1-ylazetidin-1-yl)-(1,2,3,4-tetrahydroquinolin-6-yl)methanone;1,2,3,4-tetrahydroquinoline-6-carboxylic acid;1,2,3,4-tetrahydroquinolin-6-yl-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;1,3-thiazole-2-carboxylic acid;2,2,2-trifluoro-1-[4-[1-(1,2,3,4-tetrahydroquinoline-6-carbonyl)azetidin-3-yl]piperazin-1-yl]ethanone?
The InChIKey is NJQHYHKRRYOODI-UHFFFAOYSA-M. The full InChI is InChI=1S/C21H25N5O2S.C19H23F3N4O2.C17H24N4O.C10H11NO2.C9H14F3N3O.C4H3NO2S.CH2O3.CH4O.2K.H/c27-20(16-3-4-18-15(12-16)2-1-5-22-18)26-13-17(14-26)24-7-9-25(10-8-24)21(28)19-23-6-11-29-19;20-19(21,22)18(28)25-8-6-24(7-9-25)15-11-26(12-15)17(27)14-3-4-16-13(10-14)2-1-5-23-16;22-17(14-3-4-16-13(10-14)2-1-5-19-16)21-11-15(12-21)20-8-6-18-7-9-20;12-10(13)8-3-4-9-7(6-8)2-1-5-11-9;10-9(11,12)8(16)15-3-1-14(2-4-15)7-5-13-6-7;6-4(7)3-5-1-2-8-3;2-1-4-3;1-2;;;/h3-4,6,11-12,17,22H,1-2,5,7-10,13-14H2;3-4,10,15,23H,1-2,5-9,11-12H2;3-4,10,15,18-19H,1-2,5-9,11-12H2;3-4,6,11H,1-2,5H2,(H,12,13);7,13H,1-6H2;1-2H,(H,6,7);1,3H;2H,1H3;;;/q;;;;;;;;2*+1;-1/p-1.
What are the key properties of dipotassium;1-[4-(azetidin-3-yl)piperazin-1-yl]-2,2,2-trifluoroethanone;hydride;methanol;oxido formate;(3-piperazin-1-ylazetidin-1-yl)-(1,2,3,4-tetrahydroquinolin-6-yl)methanone;1,2,3,4-tetrahydroquinoline-6-carboxylic acid;1,2,3,4-tetrahydroquinolin-6-yl-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;1,3-thiazole-2-carboxylic acid;2,2,2-trifluoro-1-[4-[1-(1,2,3,4-tetrahydroquinoline-6-carbonyl)azetidin-3-yl]piperazin-1-yl]ethanone?
dipotassium;1-[4-(azetidin-3-yl)piperazin-1-yl]-2,2,2-trifluoroethanone;hydride;methanol;oxido formate;(3-piperazin-1-ylazetidin-1-yl)-(1,2,3,4-tetrahydroquinolin-6-yl)methanone;1,2,3,4-tetrahydroquinoline-6-carboxylic acid;1,2,3,4-tetrahydroquinolin-6-yl-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;1,3-thiazole-2-carboxylic acid;2,2,2-trifluoro-1-[4-[1-(1,2,3,4-tetrahydroquinoline-6-carbonyl)azetidin-3-yl]piperazin-1-yl]ethanone has a molecular weight of 1824.18 g/mol, XLogP of -1.45, 11 rotatable bonds, 9 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for dipotassium;1-[4-(azetidin-3-yl)piperazin-1-yl]-2,2,2-trifluoroethanone;hydride;methanol;oxido formate;(3-piperazin-1-ylazetidin-1-yl)-(1,2,3,4-tetrahydroquinolin-6-yl)methanone;1,2,3,4-tetrahydroquinoline-6-carboxylic acid;1,2,3,4-tetrahydroquinolin-6-yl-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;1,3-thiazole-2-carboxylic acid;2,2,2-trifluoro-1-[4-[1-(1,2,3,4-tetrahydroquinoline-6-carbonyl)azetidin-3-yl]piperazin-1-yl]ethanone is sourced from PubChem (CID 162166477), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).